The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer : a cost estimate with real-world data
Year of publication: |
2021
|
---|---|
Authors: | Borges, Andreia ; Pereira, Filipa ; Redondo, Patrícia ; Antunes, Luís ; Vieira, Cláudia ; Antunes, Pedro ; Bento, Maria José ; Sousa, Susana ; Lopes, José Machado ; Rocha-Gonçalves, Francisco ; Sousa, Joaquim Abreu de ; Pereira, Deolinda Sousa ; Borges, Marina |
Published in: |
Health economics review. - Heidelberg : Springer, ISSN 2191-1991, ZDB-ID 2634483-X. - Vol. 11.2021, 1, Art.-No. 33, p. 1-13
|
Subject: | Pertuzumab | Neoadjuvant treatment | HER2-positive breast cancer | Cost-effectiveness analysis | Krebskrankheit | Cancer | Gesundheitskosten | Health care costs | Kosten-Wirksamkeits-Analyse |
Type of publication: | Article |
---|---|
Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
Language: | English |
Other identifiers: | 10.1186/s13561-021-00332-0 [DOI] hdl:10419/285223 [Handle] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Slegerova, Lenka, (2020)
-
Borges, Andreia, (2021)
-
Nguyen Cuc Thi Thu, (2019)
- More ...
-
Borges, Andreia, (2021)
-
The case for blockchain in IoT identity management
Sousa, Patrícia R., (2020)
-
Convergence among EU regions, 1990 - 2001: Quality of national institutions and 'Objective 1' status
Lebre de Freitas, Miguel, (2003)
- More ...